Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ceftezol
2. Ceftezol, Sodium Salt
3. Ceftezole
4. Celoslin
5. Demethylcefazolin
6. Falomesin
1. 41136-22-5
2. Falomesin
3. Celoslin
4. Alomen
5. Ceftezole Sodium [jan]
6. 3nhz4y117h
7. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 8-oxo-7-((1h-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, Monosodium Salt, (6r-trans)-
8. Ceftezole Sodium (jan)
9. Dsstox_cid_28520
10. Dsstox_rid_82792
11. Dsstox_gsid_48594
12. Sodium (6r,7r)-3-(((1,3,4-thiadiazol-2-yl)thio)methyl)-7-(2-(1h-tetrazol-1-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
13. Cas-41136-22-5
14. Ceftezole Sodium Salt
15. Ncgc00182064-02
16. Ncgc00183098-01
17. Unii-3nhz4y117h
18. Ceftezolesodium
19. Falomesin (tn)
20. Celoslin (tn)
21. Schembl1649887
22. Celoslin Sodium;falomesin Sodium
23. Dtxsid1048594
24. Chebi:31382
25. Ceftezole Sodium [mart.]
26. Ceftezole Sodium [who-dd]
27. Ceftezole Sodium Salt [mi]
28. Hy-n7096
29. Tox21_112923
30. Tox21_113140
31. Ccg-269369
32. As-83858
33. Cs-0019767
34. D01517
35. D81767
36. A899671
37. Q27257756
38. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 8-oxo-7-((2-(1h-tetrazol-1-yl)acetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-, Sodium Salt (1:1), (6r,7r)-
39. 8-oxo-7-[(1h-tetrazol-1-ylacetyl)amino]-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Monosodium Salt
40. Sodium (6r,7r)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-7-(2-(1h-tetrazol-1-yl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
41. Sodium (7r)-7-(2-(1h-tetrazol-1-yl)acetamido)-3-(1,3,4-thiadiazol-2-ylthiomethyl)-3-cephem-4-carboxylate
42. Sodium,(6r,7r)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
43. Sodium;(6r,7r)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 462.5 g/mol |
|---|---|
| Molecular Formula | C13H11N8NaO4S3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 461.99630866 g/mol |
| Monoisotopic Mass | 461.99630866 g/mol |
| Topological Polar Surface Area | 238 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 716 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
ABOUT THIS PAGE
A Falomesin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Falomesin, including repackagers and relabelers. The FDA regulates Falomesin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Falomesin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Falomesin supplier is an individual or a company that provides Falomesin active pharmaceutical ingredient (API) or Falomesin finished formulations upon request. The Falomesin suppliers may include Falomesin API manufacturers, exporters, distributors and traders.
Falomesin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Falomesin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Falomesin GMP manufacturer or Falomesin GMP API supplier for your needs.
A Falomesin CoA (Certificate of Analysis) is a formal document that attests to Falomesin's compliance with Falomesin specifications and serves as a tool for batch-level quality control.
Falomesin CoA mostly includes findings from lab analyses of a specific batch. For each Falomesin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Falomesin may be tested according to a variety of international standards, such as European Pharmacopoeia (Falomesin EP), Falomesin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Falomesin USP).
LOOKING FOR A SUPPLIER?
